134 related articles for article (PubMed ID: 1379117)
1. The role of interferons in the treatment of solid tumors.
Wadler S
Cancer; 1992 Aug; 70(4 Suppl):949-58. PubMed ID: 1379117
[TBL] [Abstract][Full Text] [Related]
2. Antineoplastic activity of the combination of interferon and cytotoxic agents against experimental and human malignancies: a review.
Wadler S; Schwartz EL
Cancer Res; 1990 Jun; 50(12):3473-86. PubMed ID: 1692761
[TBL] [Abstract][Full Text] [Related]
3. The interferons.
Itri LM
Cancer; 1992 Aug; 70(4 Suppl):940-5. PubMed ID: 1379116
[TBL] [Abstract][Full Text] [Related]
4. [Interferon in the treatment of solid tumors].
Lukac J; Seso D; Daković N; Ferencić Z; Cajkovac V; Belicza M; Soos E; Ikić D; Kusić Z
Lijec Vjesn; 1994; 116(11-12):303-7. PubMed ID: 7536287
[TBL] [Abstract][Full Text] [Related]
5. Chemotherapy and chemoimmunotherapy in disseminated malignant melanoma.
Garbe C
Melanoma Res; 1993 Aug; 3(4):291-9. PubMed ID: 7693093
[TBL] [Abstract][Full Text] [Related]
6. The role of interferons in the treatment of malignant neoplasms.
Murren JR; Buzaid AC
Yale J Biol Med; 1989; 62(3):271-90. PubMed ID: 2479178
[TBL] [Abstract][Full Text] [Related]
7. Biologic therapy of melanoma with cytokines and lymphocytes.
Bear HD; Hamad GG; Kostuchenko PJ
Semin Surg Oncol; 1996; 12(6):436-45. PubMed ID: 8914208
[TBL] [Abstract][Full Text] [Related]
8. [Interferons in the therapy of solid tumors].
Tomao S; Mozzicafreddo A; Raffaele M; Romiti A; Papò MA; Campisi C
Clin Ter; 1995; 146(8-9):491-502. PubMed ID: 8536432
[TBL] [Abstract][Full Text] [Related]
9. Current status of interferons in the treatment of cancer.
Hansen RM; Borden EC
Oncology (Williston Park); 1992 Nov; 6(11):19-24; discussion 26, 29. PubMed ID: 1280153
[TBL] [Abstract][Full Text] [Related]
10. The promise of biochemical modulation in combined modality therapy.
Vokes EE
Semin Oncol; 1994 Dec; 21(6 Suppl 14):29-33. PubMed ID: 7527598
[TBL] [Abstract][Full Text] [Related]
11. Role of biological response modifiers in immunochemotherapy of solid tumors and retroviral-induced leukemia.
Fuggetta MP; D'Onofrio C; Bonmassar E
Ann Ist Super Sanita; 1990; 26(3-4):385-95. PubMed ID: 1708953
[TBL] [Abstract][Full Text] [Related]
12. Redefining the role of interferon in the treatment of malignant diseases.
Bracarda S; Eggermont AM; Samuelsson J
Eur J Cancer; 2010 Jan; 46(2):284-97. PubMed ID: 19906524
[TBL] [Abstract][Full Text] [Related]
13. Current therapy for malignant melanoma.
Legha SS
Semin Oncol; 1989 Feb; 16(1 Suppl 1):34-44. PubMed ID: 2465575
[TBL] [Abstract][Full Text] [Related]
14. [Current status of interferon therapy].
Dittrich C
Wien Med Wochenschr; 1986 Apr; 136(7-8):163-72. PubMed ID: 2425497
[TBL] [Abstract][Full Text] [Related]
15. Rationale for intergroup trial E-3695 comparing concurrent biochemotherapy with cisplatin, vinblastine, and DTIC alone in patients with metastatic melanoma.
Flaherty LE
Cancer J Sci Am; 2000 Feb; 6 Suppl 1():S15-20. PubMed ID: 10685653
[TBL] [Abstract][Full Text] [Related]
16. Chemotherapy with [SP-4-3-(R)]-[1,1-cyclobutanedicarboxylato(2-)](2- methyl-1,4-butanediamine-N,N')platinum (CI-973, NK121) in combination with standard agents against murine tumors in vivo.
Elliott WL; Roberts BJ; Howard CT; Leopold WR
Cancer Res; 1994 Aug; 54(16):4412-8. PubMed ID: 8044790
[TBL] [Abstract][Full Text] [Related]
17. Combination of chemotherapy with interleukin-2 and interferon-alfa for the treatment of advanced melanoma.
Buzaid AC; Legha SS
Semin Oncol; 1994 Dec; 21(6 Suppl 14):23-8. PubMed ID: 7992096
[TBL] [Abstract][Full Text] [Related]
18. Sequential phase II trials of fluorouracil and interferon beta ser with or without sargramostim in patients with advanced colorectal carcinoma.
Wadler S; Haynes H; Rozenblit A; Hu X; Kaleya R; Wiernik PH
Cancer J Sci Am; 1998; 4(5):331-7. PubMed ID: 9815298
[TBL] [Abstract][Full Text] [Related]
19. Treatment of relapsed aggressive lymphomas: regimens with and without high-dose therapy and stem cell rescue.
Hagemeister FB
Cancer Chemother Pharmacol; 2002 May; 49 Suppl 1():S13-20. PubMed ID: 12042984
[TBL] [Abstract][Full Text] [Related]
20. Synergistic antitumor effects of a combination of interferons and retinoic acid on human tumor cells in vitro and in vivo.
Lindner DJ; Borden EC; Kalvakolanu DV
Clin Cancer Res; 1997 Jun; 3(6):931-7. PubMed ID: 9815768
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
